US thrilled by NIH team's Ebola vaccine candidate

The US congratulated Drs. Francis Collins and Tony Fauci and their teams at the National Institutes of Health (NIH) on the first published results from Phase 1 clinical trials of a promising Ebola vaccine candidate.
"This candidate has shown initial promise to prevent the spread of the Ebola virus infection," said White House Spokesperson Josh Earnest in a statement Wednesday.
He highlighted the work of several Department of Health and Human Services' agencies as "evidence of this Administration's determination to mount an aggressive, whole-of-government response to the Ebola crisis." Earnest added, "Today's news is another important milestone in that effort, and lays the groundwork for the critical clinical trials to follow shortly in Ebola-impacted countries to determine the safety and efficacy of Ebola vaccine candidates on a larger scale."